Kinesis Pharma (Kinesis) and Venn Life Sciences (Venn) will join forces in offering drug development services to the pharmaceutical and biotech industry as well as to investors in these areas. The companies have entered into an agreement under which Venn will acquire the entire issued share capital of Kinesis.
In a bid to stimulate the development of much needed treatments for osteoarthritis, a consortium of 24 partners comprising pharmaceutical companies, biotech companies, academic institutions, not-for-profit organizations, small and medium enterprises (SMEs) and public bodies have joined forces in the pan-European APPROACH (Applied Public-Private Research enabling OsteoArthritis Clinical Headway) project, with total research funding of 15 million Euros.
Amgen (NASDAQ:AMGN) and Dezima Pharma B.V. (Dezima) announced that the companies have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia. Dezima shareholders have approved the agreement.
Professor Barend Mons has been appointed Chair of the Commission High Level Expert Group "European Open Science Cloud", initiated by the European Commission, DG Research and Innovation.
Kite Pharma announced that it has expanded its collaboration with the Netherlands Cancer Institute (NKI). Kite and the NKI have entered into an agreement under which Kite will receive from the NKI the exclusive option to license multiple T cell receptor (TCR) gene sequences for the development and commercialization of cancer immunotherapy candidates targeting solid tumors.
This summer nine Master / PhD students from various disciplines travelled to New York, Boston, Portugal, Spain and The Netherlands with the goal to develop new insights into ALS in order to speed up the discovery of therapeutics.
Op 22 en 23 oktober vindt de eerste internationale conferentie over sociale robots in therapie en educatie plaats. De conferentie wordt georganiseerd door een internationaal consortium van universiteiten en hogescholen onder leiding van Lectoraat Robotica van Windesheim Flevoland in Almere.
We are pleased to present you the fourth edition of the bimonthly Health~Holland Update, our magazine that brings you the latest insights and developments from Health~Holland (Top Sector Life Sciences & Health).
Escher – het TI Pharma platform voor regulatoire innovatie – leidt het onderzoek in goede banen en zet Nederland internationaal op de kaart als gesprekspartner in geneesmiddelenregulering.